← Back

Wire · opportunities

FDA Clears AI Software for Subtype-Specific Sleep Apnea Classification

Published

17 July 2026

Topic

opportunities

Sectors

Digital Health

Geography

United States

Source

Read at sleepreviewmag.com

Verified

Fusion42 · 17 July 2026 · Fusion42 review

FDA has cleared HoneyNaps' SOMNUM V3.0, an AI software that automatically classifies sleep apnea subtypes (obstructive, central, mixed) from polysomnography data with 97%+ agreement, enabling more precise diagnostic scoring than manual analysis.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ The Wire takeaway

If you're building sleep diagnostics or any clinical AI that competes with manual scoring, subtype-level classification just became the regulatory floor. HoneyNaps' 510(k) path—validation via algorithmic accuracy rather than clinical outcome trials—is now a proven route to market; build to that standard and you can follow the same clearance track.

Coverage

1 source · 17 Jul 2026

Related on Wire

Topics

Digital Healthfda-510k-clearanceai-diagnosticssleep-apneaclinical-decision-supportdigital-biomarkers